Daniel Javitt, MD
Enriched profileProfessor of Psychiatry, Columbia University College of Physicians and Surgeons; Director, Division of Experimental Therapeutics · Columbia University Irving Medical Center
Daniel Javitt is Professor of Psychiatry, Columbia University College of Physicians and Surgeons; Director, Division of Experimental Therapeutics at Columbia University Irving Medical Center. OpenAlex indexes 484 publications with 43,929 citations (h-index 117); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 25 Oct 2026
Daniel Javitt, MD, PHD, is Professor of Psychiatry, Columbia University College of Physicians and Surgeons at Columbia University Irving Medical Center. The public record shows 484 publications with 43,929 citations (h-index 117), centered on Schizophrenia research and treatment, Neuroscience and Neuropharmacology Research, Hallucinations in medical conditions. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 3 companies, 27 NIH-funded awards (1986–2026).
- Most recent indexed publication: 2026 · Neuropsychopharmacology
- Top research focus: Schizophrenia research and treatment
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 317.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Sponsor: Nathan Kline Institute for Psychiatric Research
- Temporal Interference Stimulation for Social Cognition
Sponsor: Columbia University
- Neuroimaging in Patients Undergoing TMS for Depression
Sponsor: New York State Psychiatric Institute
Industry payments
Updated 25 Oct 2026
3 companies reported payments to CMS in program years 2022–2023. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20231 payment
- VoxNeuro USA Inc.Program year20221 payment
- Alkermes, Inc.Program year20221 payment
NIH funding
Updated 25 Oct 2026
27 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:
- Use of alpha-frequency deep transcranial interference stimulation (tIS) to understand and modify temporal dynamics of face emotion recognition and social/affective function.
Columbia University Health Sciences
FY2026$823,173U01MH135436 - A Schizophrenia Extension Study for the NKI Rockland Sample II project: An Open Resource of Multimodal Brain, Physiology & Behavior from a Community Lifespan Sample
Nathan S. Kline Institute for Psych Res
FY2026$820,402R01MH137769 - Glutamatergic mechanisms of psychosis and target engagement
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2026$720,368R01MH123142
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of Early Auditory Processing on Negative Symptom Response to Cognitive Remediation for Schizophrenia.
Schizophrenia bulletin
Clinical Trial2025 - Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning in schizophrenia.
Translational psychiatry
Article2023
Most-cited works
by citation count (OpenAlex)- 01Recent advances in the phencyclidine model of schizophreniaArticle2,904 citations1991
- 02
- 03
- 04
- 05The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in PsychiatryArticle808 citations2012
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/daniel-javitt-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
columbiapsychiatry.org/profile/daniel-c-javitt-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗
Mentions by others
where others cite or feature them- Other
bbrfoundation.org/node/14820
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bbrfoundation.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →columbiapsychiatry.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bbrfoundation.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bbrfoundation.org ↗
- Associate editor
Schizophrenia Bulletin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Editorial board member
Schizophrenia Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Editorial board member
American Journal of Psychiatry
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Fellow
American College of Neuropsychopharmacology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗ - Standing member
Institute of Medicine Neuro Forum
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bbrfoundation.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute for Psychiatric Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bbrfoundation.org ↗ - Director
Columbia Conte Center for Schizophrenia Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bbrfoundation.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →columbiapsychiatry.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Lawrence Honig, MD
Columbia University Irving Medical Center
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania